- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.55 Å
- Oligo State
- monomer
- Ligands
- 1 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Covalent)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 35 x IOD: IODIDE ION(Non-functional Binders)
IOD.6: 6 residues within 4Å:- Chain A: A.44, R.45, W.46, N.341, V.342, W.452
Ligand excluded by PLIPIOD.7: 3 residues within 4Å:- Chain A: L.199, R.202
- Ligands: IOD.41
Ligand excluded by PLIPIOD.8: 2 residues within 4Å:- Chain A: D.336, Q.521
Ligand excluded by PLIPIOD.9: 1 residues within 4Å:- Chain A: I.387
Ligand excluded by PLIPIOD.10: 2 residues within 4Å:- Chain A: N.80, P.145
Ligand excluded by PLIPIOD.11: 1 residues within 4Å:- Chain A: S.198
Ligand excluded by PLIPIOD.12: 2 residues within 4Å:- Chain A: S.359, A.372
Ligand excluded by PLIPIOD.13: 2 residues within 4Å:- Chain A: F.309, W.530
Ligand excluded by PLIPIOD.14: 3 residues within 4Å:- Chain A: N.284, H.286, S.592
Ligand excluded by PLIPIOD.15: 2 residues within 4Å:- Chain A: L.86, D.87
Ligand excluded by PLIPIOD.16: 4 residues within 4Å:- Chain A: K.233, P.234, S.235, E.238
Ligand excluded by PLIPIOD.22: 2 residues within 4Å:- Chain A: S.125, F.161
Ligand excluded by PLIPIOD.23: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPIOD.24: 4 residues within 4Å:- Chain A: N.95, R.96
- Ligands: NAG.4, IOD.35
Ligand excluded by PLIPIOD.25: 2 residues within 4Å:- Chain A: R.31, Y.331
Ligand excluded by PLIPIOD.26: 2 residues within 4Å:- Chain A: Q.217, F.229
Ligand excluded by PLIPIOD.27: 2 residues within 4Å:- Chain A: W.220, G.223
Ligand excluded by PLIPIOD.28: 2 residues within 4Å:- Chain A: E.373, P.375
Ligand excluded by PLIPIOD.29: 3 residues within 4Å:- Chain A: K.462, T.463, G.466
Ligand excluded by PLIPIOD.30: 3 residues within 4Å:- Chain A: H.565, A.566, F.567
Ligand excluded by PLIPIOD.31: 2 residues within 4Å:- Chain A: P.236, T.425
Ligand excluded by PLIPIOD.32: 1 residues within 4Å:- Chain A: P.573
Ligand excluded by PLIPIOD.33: 7 residues within 4Å:- Chain A: R.204, N.205, S.208, P.209, L.210, G.211, G.289
Ligand excluded by PLIPIOD.34: 1 residues within 4Å:- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.1
Ligand excluded by PLIPIOD.35: 2 residues within 4Å:- Chain A: R.506
- Ligands: IOD.24
Ligand excluded by PLIPIOD.36: 3 residues within 4Å:- Chain A: T.378, N.382, R.385
Ligand excluded by PLIPIOD.37: 4 residues within 4Å:- Chain A: R.255, F.381
- Ligands: IOD.42, IOD.47
Ligand excluded by PLIPIOD.38: 3 residues within 4Å:- Chain A: F.254, S.257, F.381
Ligand excluded by PLIPIOD.39: 2 residues within 4Å:- Chain A: E.295, Q.540
Ligand excluded by PLIPIOD.40: 2 residues within 4Å:- Chain A: H.377, H.429
Ligand excluded by PLIPIOD.41: 3 residues within 4Å:- Chain A: S.198, R.202
- Ligands: IOD.7
Ligand excluded by PLIPIOD.42: 3 residues within 4Å:- Chain A: F.254, P.424
- Ligands: IOD.37
Ligand excluded by PLIPIOD.45: 6 residues within 4Å:- Chain A: H.109, R.255, E.258
- Ligands: HEM.3, IOD.46, IOD.47
Ligand excluded by PLIPIOD.46: 5 residues within 4Å:- Chain A: R.255, E.258
- Ligands: HEM.3, IOD.45, IOD.47
Ligand excluded by PLIPIOD.47: 5 residues within 4Å:- Chain A: E.258, F.381
- Ligands: IOD.37, IOD.45, IOD.46
Ligand excluded by PLIP- 5 x SCN: THIOCYANATE ION(Non-functional Binders)
SCN.17: 2 residues within 4Å:- Chain A: D.16, E.17
No protein-ligand interaction detected (PLIP)SCN.18: 6 residues within 4Å:- Chain A: E.363, Y.365, R.397, I.559, T.560, K.561
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:K.561
SCN.19: 5 residues within 4Å:- Chain A: S.459, P.461, G.466, T.469, V.470
No protein-ligand interaction detected (PLIP)SCN.20: 3 residues within 4Å:- Chain A: N.241, T.242, T.243
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:T.243
SCN.43: 5 residues within 4Å:- Chain A: R.76, N.80, P.149, R.418, N.419
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.76, A:R.418
- 1 x CA: CALCIUM ION(Non-covalent)
- 1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Viswanathan, V. et al., Structure of Yak Lactoperoxidase at 1.55 angstrom Resolution. Protein J. (2021)
- Release Date
- 2020-11-25
- Peptides
- Lactoperoxidase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.55 Å
- Oligo State
- monomer
- Ligands
- 1 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Covalent)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 35 x IOD: IODIDE ION(Non-functional Binders)
- 5 x SCN: THIOCYANATE ION(Non-functional Binders)
- 1 x CA: CALCIUM ION(Non-covalent)
- 1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Viswanathan, V. et al., Structure of Yak Lactoperoxidase at 1.55 angstrom Resolution. Protein J. (2021)
- Release Date
- 2020-11-25
- Peptides
- Lactoperoxidase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A